Sort
25,944 grants matching “neurodegeneration”
Molecular Basis of rCGG-Mediated Neurodegeneration
$759,282Peng Jin · Emory University · R01 · FY2012 · NS
Biological Analysis Core
$759,276Andrew B Nixon · Duke University · U54 · FY2021 · AG
White matter degeneration: biomarkers in preclinical Alzheimer's Disease
$759,193Barbara Brigitta Bendlin · University Of Wisconsin-Madison · R01 · FY2019 · AG
White matter degeneration: biomarkers in preclinical Alzheimer's Disease
$759,193Barbara Brigitta Bendlin · University Of Wisconsin-Madison · R01 · FY2020 · AG
Transcranial direct current stimulation in typical and atypical Alzheimer's disease
$759,034Kyrana Tsapkini · Johns Hopkins University · R01 · FY2021 · AG
Glycolysis and rodent models of Alzheimer's disease
$758,745Qiang Zhang · University Of Iowa · R01 · FY2025 · AG
Blood-Brain Barrier Dysfunction in Alzheimerâs Disease: New Mechanistic Insights and Therapeutic Strategies
$758,744Anika M.s. Hartz · University Of Kentucky · R01 · FY2025 · AG
COBRE: U NEL: ADMIN: NEBRASKA REDOX BIOLOGY CENTER
$758,720Donald F Becker · University Of Nebraska Lincoln · P20 · FY2011 · RR
Saracatinib and 1400W Counteract Nerve Agents-Induced Long-Term Neurotoxicity
$758,641Thimmasettappa Thippeswamy · Iowa State University · U01 · FY2023 · NS
White matter degeneration: biomarkers in preclinical Alzheimer's Disease
$758,631Barbara Brigitta Bendlin · University Of Wisconsin-Madison · R56 · FY2017 · AG
Changes across the lifespan in the use of heuristics to guide decision-making
$758,584Michele A Basso · University Of California Los Angeles · R01 · FY2019 · AG
Changes across the lifespan in the use of heuristics to guide decision-making
$758,584Michele A Basso · University Of California Los Angeles · R01 · FY2020 · AG
SV2A PET imaging in Alzheimer's Disease
$758,565Barbara Brigitta Bendlin · University Of Wisconsin-Madison · R01 · FY2018 · AG
Saracatinib and 1400W Counteract Nerve Agents-Induced Long-Term Neurotoxicity
$758,516Thimmasettappa Thippeswamy · Iowa State University · U01 · FY2025 · NS
Epigenomic analysis of neural circuits in Alzheimer's disease mouse models
$758,446Xiangmin Xu · University Of California-Irvine · R01 · FY2022 · AG
Development of EP2 receptor antagonists for suppression of Alzheimer's neuropathology
$758,149Thota Ganesh · Emory University · U01 · FY2016 · AG
Amyloidosis associated proteins in Alzheimerâs disease pathogenesis
$757,775Stefan Prokop · University Of Florida · R01 · FY2024 · AG
DYRK1A Inhibition as a Novel Treatment Approach for Alzheimer's Disease
$757,693Christopher Hulme · University Of Arizona · R01 · FY2021 · AG
Immune Cells in Alzheimerâs Disease and Related Dementias in the Jackson Heart Study
$757,676Laura M Raffield · Univ Of North Carolina Chapel Hill · R01 · FY2024 · AG
Use of High Density Lipoprotein Proteome in the Prediction of Cognitive Impairment and Alzheimer's Disease: (REGARDS)
$757,603Robert Sidney Rosenson · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · AG
Discovery of Selective Inhibitors for the EphA4 Kinase
$757,556Eduard A. Sergienko · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · AG
Linking olfactory deficits to memory impairment and AD neurodegeneration
$757,512Prasanna Rasika Karunanayaka · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2025 · AG
The Beaver Dam Offspring Study Neurocognitive Aging Study (BOSS-NCAS)-A Study on the Role of Accelerated Aging and Midlife Sensory Decline for Early Alzheimerâs Disease and Dementia in Later Life
$757,350Natascha Merten · University Of Wisconsin-Madison · R01 · FY2023 · AG
Identifying Regulators of Degeneration due to Defective Mitochondrial DNA
$757,254Ming Guo · University Of California Los Angeles · R01 · FY2022 · AG
Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: A Randomized Clinical Trial
$757,048Barry W Rovner · Thomas Jefferson University · R01 · FY2023 · AG